Okami Medical ALPHA Registry

NCT07525518 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-05-22

No results posted yet for this study

Summary

This registry will provide insights into the use of Okami Medical devices in real-world clinical and study effectiveness and safety of Okami Medical devices.

Conditions

  • Arterial Bleed
  • Pulmonary Arteriovenous Malformation
  • Embolization
  • Hemorrhage

Interventions

DEVICE

LOBO Vascular Occlusion System

LOBO Vascular Occlusion System

Sponsors & Collaborators

  • Okami Medical, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-31
Primary Completion
2030-08-31
Completion
2030-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07525518 on ClinicalTrials.gov